18July
Narayanan S, Gala S. Merkel Cell Carcinoma
Epidemiology, Disease Burden and Unmet Needs. Submitted to Head and Neck. In Review.
Category Archives: Manuscripts
18July
Narayanan S, Mainz J, Gala S, Tabori H, Grossoehm D
Adherence to Therapies in Cystic Fibrosis: A Targeted Literature Review. Submitted to Exp Rev in Resp Med. In Review.
18July
Bradshaw S, Gala S, Nanavaty M, Shah A, Mwamburi M, Kefalas P
Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion. BMC Ophthalmology.
18July
Nanavaty M, Kaura S, Mwamburi M, Gogate A, Proach J, Nyandege A, Khan Z.
The Use of Incremental Cost-Effectiveness Ratio Thresholds in Health Technology Assessment Decisions. Journal of Clinical Pathways.
18July
Burudpakdee C, Khan Z, Gala S, Nanavaty M, Kaura S
Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis. Patient preference and adherenc.
18July
Nyandege A, Slattum P, Harpe S
Risk of Fracture and the Concomitant Use of Bisphosphonates With Osteoporosis-Inducing Medications. Annals of Pharmacotherapy.
18July
Burudpakdee C, Gala S, Nanavaty M, G Mallya U
The economic burden of psoriasis: a systematic literature review. Expert review of pharmacoeconomics & outcomes research.
18July
Shortridge E, Polzer P, Donga P, Blanchette C, Fang Y, Burudpakdee C
Experiences and treatment patterns of hypogonadal men in a U.S. health system. International Journal of Clinical Practice.
18July
Gala S, Wu WFactors affecting adherence and access to the recommended level of diabetes care in adults with type II diabetes. Journal of Pharmaceutical Health Services Research.
Factors affecting adherence and access to the recommended level of diabetes care in adults with type II diabetes. Journal of Pharmaceutical Health Services Research.
18July
Burudpakdee C, Shah A, Joish V, Divers C, Yaldo A
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension. American Health & Drug Benefits.